Viz.ai Launches Viz ACS™ to Accelerate Treatment for Heart Attack and Reduce Unnecessary Activations

New solution helps reduce false activations through real-time data sharing and team coordination

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of Viz ACS, a new solution in the Viz Cardio™ Suite. Designed to unite the acute coronary syndrome (ACS) care team on a single platform, Viz ACS provides Emergency Department (ED) physicians and cardiologists with the same high-quality ECGs and patient data in real time. This streamlined workflow can help improve communication, speeds treatment, and reduces unnecessary cath lab activations.

“Viz ACS gives immediate access to ambulance and ED ECGs all in one place,” said Dr. Gregory Means, a practicing interventional cardiologist. “Instead of blurry text messages, I can coordinate with EMS, ED, and cath lab teams in a HIPAA-compliant environment, and activate the cath lab only when needed. This saves time, avoids false alarms, and ensures patients are ready for percutaneous coronary intervention (PCI) as soon as they arrive.”

Viz ACS consolidates ECGs from the ambulance, emergency department, and prior encounters into a HIPAA-compliant mobile viewer, giving cardiologists immediate access to a patient’s full history to track serial changes and interpret the latest ECG in context. When a heart attack is suspected, ED teams can escalate directly to the on-call interventional cardiologist, who can review ECGs and patient data in real time and activate the cath lab with a single click. This secure, streamlined workflow replaces screenshots and fragmented text chains with improved coordination across the care team.

“From our earliest work in stroke, Viz has focused on harnessing technology to give physicians the tools they need to act faster and coordinate care when every second counts,” said Dr. Andrew M. Ibrahim, MD, MSc, chief clinical officer at Viz.ai. “With Viz ACS, we’re expanding that commitment into cardiology, bringing the same proven approach to acute cardiac conditions where speed is critical. The addition of ACS is another step toward our vision of an enterprise-wide solution that spans specialties—making it easier for health systems to care for every patient, in every corner of healthcare.”

Viz ACS builds on Viz.ai’s leadership in acute care coordination and significantly advances Viz’s mission to increase access to life-saving treatments. In 2025, Viz.ai was ranked the #1 AI-Powered Acute Care Platform by hospitals and health systems in the Black Book™ Research survey, leading in 11 key performance indicators—more than any other vendor—underscoring its unmatched effectiveness in acute care workflows.

To learn more about Viz ACS, visit viz.ai/viz-acs.

About Viz.ai

Viz.ai is the leader in AI-powered care coordination and clinical workflow solutions, deployed in over 1,800 hospitals across the U.S. and trusted by most of the top life sciences companies. Its platform uses artificial intelligence to detect diseases earlier, synchronize care teams, and ensure patients get to the right treatment faster. Viz.ai was the first company awarded CMS reimbursement for AI and ranked the #1 Healthcare AI Platform by hospitals and health systems in the Black Book Research survey, setting the standard for innovation in healthcare. For more information visit Viz.ai.